We are thrilled to share a significant milestone in the mission to end sarcoma. CRBF, in collaboration with the Tom Hardyman Sarcoma Research Fund and Tour de Cure Spring Lunch—on behalf of the Andrew Dreverman Legacy for Sarcoma Research Fund—has proudly co-funded groundbreaking research that has led to the launch of a new sarcoma-focused programme through Omico Australia.
In November 2023, the Tour de Cure Spring Lunch raised an incredible $1.3 million in just four hours—an outstanding achievement. The beneficiaries included CRBF and, most importantly, the sarcoma community, alongside funding for onco-fertility support for young patients at the Royal Women’s Hospital Sydney. The Spring Lunch showcases the incredible work of a remarkable team, together with Dominique Robinson, her daughter Cassandra Prothero and Dom’s bother Bruno Maurel, OAM.
On Sunday February 16, the MoST/CaSP/Sarc programme was officially launched and will exist under the leadership of Professor David Thomas and Dr. Maya Kansara. We are beyond grateful to them and to their team for the work they have placed into this pivotal programme.
Expected to be the largest of its kind globally, this programme will encompass a cohort of over 3,000 patients with international reach—an essential step forward in advancing sarcoma research and treatment.
Special thanks to Phil Baker the CRBF Media and PR Consultant who volunteers his expertise to bring these stories together.